Wang, M., Han, J., Marcar, L., Black, J., Liu, Q., Li, X., . . . Willers, H. (2017). Radiation resistance in KRAS-mutated lung cancer is enabled by stem-like properties mediated by an osteopontin-EGFR pathway. Cancer Res.
استشهاد بنمط شيكاغوWang, Meng, et al. "Radiation Resistance in KRAS-mutated Lung Cancer Is Enabled By Stem-like Properties Mediated By an Osteopontin-EGFR Pathway." Cancer Res 2017.
MLA استشهادWang, Meng, et al. "Radiation Resistance in KRAS-mutated Lung Cancer Is Enabled By Stem-like Properties Mediated By an Osteopontin-EGFR Pathway." Cancer Res 2017.
تحذير: قد لا تكون هذه الاستشهادات دائما دقيقة بنسبة 100%.